AXM Pharma, Inc.
Pharmaceutical firm focused on Asian markets reports $0.16 per share loss
Published in Lab Business Week, December 25th, 2005
Revenue for the third quarter of 2005 totaled approximately $224,000; in the comparable period in 2004, the company had no operating revenues. While the company has not yet completed its preparation of its third quarter financial statements, it currently estimates that its net loss for the period was approximately $3.3 - 3.6 million, or $0.16 - 0.18 per fully diluted share, compared to a net loss of $3,148,745 for the comparable period in 2004, or $0.22 per fully diluted share.
The company has had to delay the filing of its report on Form...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-12-25)
More Articles from Lab Business Week
- 3M
Drug delivery device maker amends zero coupon senior convertible notes - Acadia Pharmaceuticals, Inc.
Neuroscience-focused pharmaceutical firm reports loss of $12.3M - American Oriental Bioengineering, Inc.
Chinese biotech firm's common stock approved for listing on the Archipelago Exchange - AmerisourceBergen Corp.
Pharmaceutical services company doubles quarterly dividend and splits stock two-for-one - Arius Research, Inc.
Cancer drug developer secures US$2M funding commitment - Bayer Group
Aspirin maker reports that operating result doubled in third quarter - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
